Quadrivalent HPV vaccination
Quadrivalent HPV vaccination refers to immunization with a human papillomavirus vaccine designed to protect against four HPV types, classically including the oncogenic types HPV 16 and 18 and the low-risk types HPV 6 and 11.
Quadrivalent HPV vaccination refers to immunization with a human papillomavirus vaccine designed to protect against four HPV types, classically including the oncogenic types HPV 16 and 18 and the low-risk types HPV 6 and 11. Biologically, this vaccine is intended to reduce infection with HPV types that contribute to cervical and other anogenital Cancers as well as genital warts. As a preventive Therapy, its clinical significance lies in lowering the incidence of HPV-associated disease before exposure to the virus.
In public health practice, quadrivalent HPV vaccination has been used in national and regional immunization programs to reduce HPV transmission and downstream disease burden. Its effects are typically evaluated at the population level through changes in vaccination uptake, HPV-related lesions, and Cancer precursor outcomes rather than through direct treatment of established disease. In the recent studies summarized below, the vaccine was examined in relation to adolescent vaccine communication, sexual behavior concerns, and early changes in high-grade cervical intraepithelial neoplasia, including in the context of recurrent cervical cancer risk reduction efforts.
Where the papers sit
9 papers from the last 6 months study Quadrivalent HPV vaccination directly · updated from PubMed 20 Oct 2026
Study type 0 clinical trials · 3 observational · 6 human data
Themes one subject
Those 9 are all about one subject.
-
HPV Vaccination Uptake
HPV vaccination uptake is being approached through parent and student education, provider communication, and service-access strategies. Training for clinicians and school nurses, theory-based recommendations, and educational interventions aim to improve knowledge, acceptability, and intention to vaccinate. Social media is used to maintain services during disruption, while qualitative and cross-sectional work identifies persistent gaps in access and confidence across settings. Early Brazilian outpatient data begin to assess effects on high-grade cervical intraepithelial neoplasia, while links with sexual debut remain unresolved.
Papers
The 9 papers from the last 6 months that study Quadrivalent HPV vaccination directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
HPV Vaccination Uptake (9)
- Leveraging social media to mitigate HPV vaccine service disruptions in Abuja, Nigeria. PloS one · 9 Jul 2026 PMID 42424332
- Development of a theory-based provider-focused training to improve HPV vaccine recommendations for young adults. Human vaccines & immunotherapeutics · 8 Jul 2026 PMID 42415470
- Perceptions, knowledge, and access to the HPV vaccine among parents and healthcare providers in South Quito, Ecuador in 2025: A qualitative study. Global public health · 3 Jul 2026 PMID 42396795
- Effectiveness of an educational intervention in enhancing parents' knowledge, perception, and acceptability of human papillomavirus vaccine. BMC public health · 3 Jul 2026 PMID 42393589
- Knowledge of human papillomavirus and vaccination attitudes among female university students in Turkey: A cross-sectional study. African journal of reproductive health · 26 Jun 2026 PMID 42359782
- Impact of school nurse education on factors influencing HPV vaccine communication with parents. Human vaccines & immunotherapeutics · 23 Jun 2026 PMID 42334842
- Early effects of HPV vaccination on high-grade cervical intraepithelial neoplasia in Brazil: Evidence from outpatient data. Human vaccines & immunotherapeutics · 15 Jun 2026 PMID 42295873
- Factors associated with intention to obtain HPV vaccination at ages 9-10 among parents with varied prior vaccine decision making experiences and choices. Vaccine · 14 May 2026 PMID 42134134
- HPV vaccine and age of sexual debut of adolescents: A nationwide cross-sectional study. Vaccine · 9 May 2026 PMID 42105393
By study type
Observational studies and case reports (3)
- Leveraging social media to mitigate HPV vaccine service disruptions in Abuja, Nigeria. PloS one · 9 Jul 2026 PMID 42424332
- Knowledge of human papillomavirus and vaccination attitudes among female university students in Turkey: A cross-sectional study. African journal of reproductive health · 26 Jun 2026 PMID 42359782
- HPV vaccine and age of sexual debut of adolescents: A nationwide cross-sectional study. Vaccine · 9 May 2026 PMID 42105393
Human data, design not indexed (6)
- Development of a theory-based provider-focused training to improve HPV vaccine recommendations for young adults. Human vaccines & immunotherapeutics · 8 Jul 2026 PMID 42415470
- Perceptions, knowledge, and access to the HPV vaccine among parents and healthcare providers in South Quito, Ecuador in 2025: A qualitative study. Global public health · 3 Jul 2026 PMID 42396795
- Effectiveness of an educational intervention in enhancing parents' knowledge, perception, and acceptability of human papillomavirus vaccine. BMC public health · 3 Jul 2026 PMID 42393589
- Impact of school nurse education on factors influencing HPV vaccine communication with parents. Human vaccines & immunotherapeutics · 23 Jun 2026 PMID 42334842
- Early effects of HPV vaccination on high-grade cervical intraepithelial neoplasia in Brazil: Evidence from outpatient data. Human vaccines & immunotherapeutics · 15 Jun 2026 PMID 42295873
- Factors associated with intention to obtain HPV vaccination at ages 9-10 among parents with varied prior vaccine decision making experiences and choices. Vaccine · 14 May 2026 PMID 42134134
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-07-09. Last written: 2026-08-27 by GPT. Drafted by language models from published abstracts; not medical advice.